Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current HIV/AIDS Reports
Erschienen in: Current HIV/AIDS Reports 4/2013

01.12.2013 | Behavioral Aspects of HIV Management (RJ DiClemente and JL Brown, Section Editors)

Intimate Partner Violence and HIV: A Review

verfasst von: Reed A. C. Siemieniuk, Hartmut B. Krentz, M. John Gill

Erschienen in: Current HIV/AIDS Reports | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

Intimate partner violence (IPV) is a common and negative social determinant of health. IPV also increases vulnerability to risks associated with HIV transmission and contributes to HIV transmission. IPV is therefore predictably common among people living with HIV. It is increasingly being recognized as an important predictor of poor outcomes for those living with HIV by affecting retention to care, mental health, adherence to therapy, frequency of follow-up; all of which lead to more hospitalizations and progression to AIDS. HIV care providers can safely and effectively screen all HIV patients for IPV. Screening offers the opportunity to identify those at risk for poor outcomes and mitigate its effects. Further research is required in further defining the risk factors and outcomes of IPV and optimizing interventions. We review the association between HIV infection and IPV and make recommendations for IPV screening of HIV-positive individuals and those at high risk for HIV.
Literatur
1.
2.
3.
Singer M. A dose of drugs, a touch of violence, a case of AIDS: conceptualizing the SAVA syndemic. Free Inq Creat Sociol. 1996;24:99–110.
4.
5.
Maman S, Campbell J, Sweat MD, Gielen AC. The intersections of HIV and violence: directions for future research and interventions. Soc Sci Med. 2000;50:459–78.PubMedCrossRef
6.
Were E, Curran K, Delany-Moretlwe S, et al. A prospective study of frequency and correlates of intimate partner violence among African heterosexual HIV serodiscordant couples. AIDS. 2011;25:2009–18.PubMedCrossRef
7.
Andersson N, Cockcroft A. Choice-disability and HIV infection: a cross sectional study of HIV status in Botswana, Namibia and Swaziland. AIDS Behav. 2012;16:189–98.PubMedCrossRef
8.
Kayibanda JF, Bitera R, Alary M. Violence toward women, men's sexual risk factors, and HIV infection among women: findings from a national household survey in Rwanda. J Acquir Immune Defic Syndr. 2012;59:300–7.PubMedCrossRef
9.
Machtinger EL, Wilson TC, Haberer JE, et al. Psychological trauma and PTSD in HIV-positive women: a meta-analysis. AIDS Behav. 2012;16:2091–100.PubMedCrossRef
10.
Hyginus E, Chukwuemeka I, Lawrence I, et al. HIV-related intimate partner violence among pregnant women in Nigeria. East Afr J Public Health. 2012;9:29–32.PubMed
11.
Shamu S, Abrahams N, Temmerman M, Musekiwa A, Zarowsky C. A systematic review of African studies on intimate partner violence against pregnant women: prevalence and risk factors. PLoS One. 2011;6:e17591.PubMedCrossRef
12.
Barros C, Schraiber LB, França-Junior I. Association between intimate partner violence against women and HIV infection. Rev Saude Publica. 2011;45:365–72.PubMedCrossRef
13.
Harling G, Msisha W, Subramanian SV. No association between HIV and intimate partner violence among women in 10 developing countries. PLoS One. 2010;5:e14257.PubMedCrossRef
14.
Sareen J, Pagura J, Grant B. Is intimate partner violence associated with HIV infection among women in the United States? Gen Hosp Psychiatry. 2009;31:274–8.PubMedCrossRef
15.
Decker MR, Seage 3rd GR, Hemenway D, et al. Intimate partner violence functions as both a risk marker and risk factor for women's HIV infection: findings from Indian husband-wife dyads. J Acquir Immune Defic Syndr. 2009;51:593–600.PubMedCrossRef
16.
Prabhu M, McHome B, Ostermann J, KIWAKKUKI-Duke VCT Study Group, et al. Prevalence and correlates of intimate partner violence among women attending HIV voluntary counseling and testing in northern Tanzania, 2005-2008. Int J Gynaecol Obstet. 2011;113:63–7.PubMedCrossRef
17.
Parsons JT, Grov C, Golub SA. Sexual compulsivity, co-occurring psychosocial health problems, and HIV risk among gay and bisexual men: further evidence of a syndemic. Am J Public Health. 2012;102:156–62.PubMedCrossRef
18.
Li Y, Baker JJ, Korostyshevskiy VR, et al. The association of intimate partner violence, recreational drug use with HIV seroprevalence among MSM. AIDS Behav. 2012;16:491–8.PubMedCrossRef
19.
Greenwood GL, Relf MV, Huang B, et al. Battering victimization among a probability-based sample of men who have sex with men. Am J Public Health. 2002;92:1964–9.PubMedCrossRef
20.
Brennan J, Kuhns LM, Johnson AK, Adolescent Medicine Trials Network for HIV/AIDS Interventions, et al. Syndemic theory and HIV-related risk among young transgender women: the role of multiple, co-occurring health problems and social marginalization. Am J Public Health. 2012;102:1751–7.PubMedCrossRef
21.
Jewkes RK, Dunkle K, Nduna M, et al. Intimate partner violence, relationship power inequity, and incidence of HIV infection in young women in South Africa: a cohort study. Lancet. 2010;376:41–8.PubMedCrossRef
22.
•• Kouyoumdjian FG, Calzavara LM, Bondy SJ, et al. Intimate partner violence is associated with incident HIV infection in women in Uganda. AIDS. 2013;27:1331–8. This is the largest prospective study to date of IPV on risk of incident HIV infection. The authors followed over 4000 Ugandan women for two years and found 55% increased adjusted odd of HIV infection of women who have experienced IPV. The risk of HIV infection did not seem to differ between types of IPV. The risk of HIV was not mediated by condom use or number of past-year sexual partners.PubMed
23.
Gray RH, Wawer MJ, Brookmeyer R, Rakai Project Team, et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet. 2001;357:1149–53.PubMedCrossRef
24.
• Stockman JK, Lucea MB, Campbell JC. Forced Sexual Initiation, Sexual Intimate Partner Violence and HIV Risk in Women: A Global Review of the Literature. AIDS Behav. 2013;17:832–47. A narrative review of the literature since 2000 on sexual violence, including sexual IPV, and risk of HIV infection. Authors suggest that when surveys are conducted using specific and culture-sensitive terms, there is a strong association between sexual IPV and HIV infection.PubMedCrossRef
25.
Morokoff PJ, Redding CA, Harlow LL, et al. Associations of sexual victimization, depression, and sexual assertiveness with unprotected sex: a test of the multifaceted model of HIV risk across gender. J Appl Biobehav Res. 2009;14:30–54.CrossRef
26.
Mittal M, Senn TE, Carey MP. Mediators of the relation between partner violence and sexual risk behavior among women attending a sexually transmitted disease clinic. Sex Transm Dis. 2011;38:510–5.PubMed
27.
Varghese B, Maher JE, Peterman TA, Branson BM, Steketee RW. Reducing the risk of sexual HIV transmission: quantifying the per-act risk for HIV on the basis of choice of partner, sex act, and condom use. Sex Transm Dis. 2002;29:38–43.PubMedCrossRef
28.
Deering KN, Bhattacharjee P, Mohan HL, et al. Violence and HIV risk among female sex workers in Southern India. Sex Transm Dis. 2013;40:168–74.PubMed
29.
Peragallo N, Gonzalez-Guarda RM, McCabe BE, et al. The efficacy of an HIV risk reduction intervention for Hispanic women. AIDS Behav. 2012;16:1316–26.PubMedCrossRef
30.
Zhang C, Li X, Hong Y, et al. Partner violence and HIV risk among female sex workers in China. AIDS Behav. 2012;16:1020–30.PubMedCrossRef
31.
Swan H, O'Connell DJ. The impact of intimate partner violence on women's condom negotiation efficacy. J Interpers Violence. 2012;27:775–92.PubMedCrossRef
32.
El-Bassel N, Gilbert L, Witte S, et al. Intimate partner violence and HIV among drug-involved women: contexts linking these two epidemics–challenges and implications for prevention and treatment. Subst Use Misuse. 2011;46:295–306.PubMedCrossRef
33.
Coker AL. Does physical intimate partner violence affect sexual health? A systematic review. Trauma Violence Abuse. 2007;8:149–77.PubMedCrossRef
34.
Wingood GM, DiClemente RJ. The effects of an abusive primary partner on the condom use and sexual negotiation practices of African-American women. Am J Public Health. 1997;87:1016–8.PubMedCrossRef
35.
Galvin SR, Cohen MS. The role of sexually transmitted diseases in HIV transmission. Nat Rev Microbiol. 2004;2:33–42.PubMedCrossRef
36.
Aceijas C, Stimson GV, Hickman M, et al. United Nations Reference Group on HIV/AIDS Prevention and Care among IDU in Developing and Transitional Countries. Global overview of injecting drug use and HIV infection among injecting drug users. AIDS. 2004;18:2295–303.PubMedCrossRef
37.
Kral AH, Bluthenthal RN, Lorvick J, et al. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet. 2001;357:1397–401.PubMedCrossRef
38.
El-Bassel N, Gilbert L, Wu E, et al. Relationship between drug abuse and intimate partner violence: A longitudinal study among women receiving methadone. Am J Public Health. 2005;94:465–70.CrossRef
39.
Shamu S, Abrahams N, Temmerman M, et al. "That pregnancy can bring noise into the family": exploring intimate partner sexual violence during pregnancy in the context of HIV in Zimbabwe. PLoS One. 2012;7:e43148.PubMedCrossRef
40.
El-Bassel N, Gilbert L, Wu E, et al. Perpetration of intimate partner violence among men in methadone treatment programs in New York City. Am J Public Health. 2007;97:1230–2.PubMedCrossRef
41.
Jewkes R, Sikweyiya Y, Morrell R, et al. The relationship between intimate partner violence, rape and HIV amongst South African men: a cross-sectional study. PLoS One. 2011;6:e24256.PubMedCrossRef
42.
Raj A, Santana MC, La Marche A, et al. Perpetration of intimate partner violence associated with sexual risk behaviors among young adult men. Am J Public Health. 2006;96:1873–8.PubMedCrossRef
43.
Gilbert L, El-Bassel N, Wu E, et al. Intimate partner violence and HIV risks: a longitudinal study of men on methadone. J Urban Health. 2007;84:667–80.PubMedCrossRef
44.
Iliyasu Z, Abubakar IS, Babashani M, et al. Domestic violence among women living with HIV/AIDS in Kano. Northern Nigeria. Afr J Reprod Health. 2011;15:41–9.PubMed
45.
• Ramachandran S, Yonas MA, Silvestre AJ, et al. Intimate partner violence among HIV-positive persons in an urban clinic. AIDS Care. 2010;22:1536–43. A qualitative study of HIV patients, exploring perceptions of screening for IPV within a healthcare setting. IPV screening was well-accepted by almost all patients (95%), however there was concern about repercussions if screening was not done in a confidential manner.PubMedCrossRef
46.
Thompson M, Kingree J. The Roles of Victim and Perpetrator Alcohol Use in Intimate Partner Violence Outcomes. J Interpers Violence. 2006;21:163–77.PubMedCrossRef
47.
Siemieniuk RA, Krentz HB, Gish JA, et al. Domestic violence screening: prevalence and outcomes in a Canadian HIV population. AIDS Patient Care STDs. 2010;24:763–70.PubMedCrossRef
48.
•• Siemieniuk RA, Krentz HB, Miller P, et al. The clinical implications of high rates of intimate partner violence against HIV-positive women. J Acquir Immune Defic Syndr. 2013 May 24. [Epub ahead of print]. This is the first population-based study of the clinical impact IPV among 339 HIV-infected women. IPV was common (40%) and was associated with increased HIV-related and HIV-unrelated hospitalizations. The patients who experienced IPV had less use of ART and were more frequently lost to follow-up, which may explain the poor outcomes.
49.
Dhairyawan R, Tariq S, Scourse R, et al. Intimate partner violence in women living with HIV attending an inner city clinic in the UK: prevalence and associated factors. HIV Med. 2013;14:303–10.PubMedCrossRef
50.
Aryal N, Regmi PR, Mudwari NR. Violence against women living with HIV: a cross sectional study in Nepal. Glob J Health Sci. 2012;4:117–25.PubMed
51.
Osinde MO, Kaye DK, Kakaire O. Intimate partner violence among women with HIV infection in rural Uganda: critical implications for policy and practice. BMC Womens Health. 2011;11:50.PubMedCrossRef
52.
•• Siemieniuk RA, Miller P, Woodman K, et al. Prevalence, clinical associations, and impact of intimate partner violence among HIV-infected gay and bisexual men: a population-based study. HIV Med. 2013;14:293–302. A population-based study of almost 700 gay and bisexual HIV-infected men in Canada. This study showed an IPV prevalence of almost one in four and victims of IPV had a higher rate of HIV-related hospitalizations and progression to AIDS after having the opportunity to engage in medical care.PubMedCrossRef
53.
Pantalone DW, Schneider KL, Valentine SE, et al. Investigating partner abuse among HIV-positive men who have sex with men. AIDS Behav. 2012;16:1031–43.PubMedCrossRef
54.
Kalokhe AS, Paranjape A, Bell CE, et al. Intimate partner violence among HIV-infected crack cocaine users. AIDS Patient Care STDS. 2012;26:234–40.PubMed
55.
Campbell J, Garcia-Moreno C, Sharps P. Abuse during pregnancy in industrialized and developing countries. Violence against women. 2004;10:770–89.
56.
Ezechi OC, Gab-Okafor C, Onwujekwe DI, et al. Intimate partner violence and correlates in pregnant HIV positive Nigerians. Arch Gynecol Obstet. 2009;280:745–52.PubMedCrossRef
57.
Ezeanochie MC, Olagbuji BN, Ande AB, et al. Prevalence and correlates of intimate partner violence against HIV-seropositive pregnant women in a Nigerian population. Acta Obstet Gynecol Scand. 2011;90:535–9.PubMedCrossRef
58.
Mays VM, Cochran SD. Mental health correlates of perceived discrimination among lesbian, gay, and bisexual adults in the United States. Am J Public Health. 2001;91:1869–76.PubMedCrossRef
59.
Ellsberg M, Jansen HA, Heise L, et al. Intimate partner violence and women’s physical and mental health in the WHO multi-country study on women’s health and domestic violence: An observational study. Lancet. 2008;371:1165–72.PubMedCrossRef
60.
Carrico AW, Riley ED, Johnson MO, et al. Psychiatric risk factors for HIV disease progression: the role of inconsistent patterns of antiretroviral therapy utilization. J Acquir Immune Defic Syndr. 2011;56:146–50.PubMedCrossRef
61.
Illangasekare S, Tello M, Hutton H, et al. Clinical and mental health correlates and risk factors for intimate partner violence among HIV-positive women in an inner-city HIV clinic. Womens Health Issues. 2012;22:e563–9.PubMedCrossRef
62.
Cunningham WE, Crystal S, Bozzette S, et al. The association of health-related quality of life with survival among persons with HIV infection in the United States. J Gen Intern Med. 2005;20:21–7.PubMedCrossRef
63.
• Schafer KR, Brant J, Gupta S, et al. Intimate partner violence: a predictor of worse HIV outcomes and engagement in care. AIDS Patient Care STDS. 2012;26:356–65. A cohort study that showed HIV-infected patients who experienced IPV more often had an uncontrolled viral load, lower CD4 counts, and were more likely to miss appointments.PubMedCrossRef
64.
Aberg JA, Kaplan JE, Libman H, HIV Medicine Association of the Infectious Diseases Society of America, et al. Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2009;49:651–81.PubMedCrossRef
65.
Institute of Medicine. Recommendations. In: Clinical preventive services for women: closing the gaps. Washington, DC: National Academies Press; 2011. p. 71–141.
66.
American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 518: Intimate partner violence. Obstet Gynecol. 2012;119:412–7.
67.
Moyer VA, U.S. Preventive Services Task Force. Screening for intimate partner violence and abuse of elderly and vulnerable adults: U.S. preventive services task force recommendation statement. Ann Intern Med. 2013;158:478–86.PubMedCrossRef
68.
Christofides N, Jewkes R. Acceptability of universal screening for intimate partner violence in voluntary HIV testing and counseling services in South Africa and service implications. AIDS Care. 2010;22:279–85.PubMedCrossRef
69.
Wingood GM, DiClemente RJ, Harrington KF, et al. Efficacy of an HIV prevention program among female adolescents experiencing gender-based violence. Am J Public Health. 2006;96:1085–90.PubMedCrossRef
70.
Rabin RF, Jennings JM, Campbell JC, et al. Intimate partner violence screening tools: a systematic review. Am J Prev Med. 2009;36:439–45.PubMedCrossRef
71.
Vickerman KA, Margolin G. Rape treatment outcome research: empirical findings and state of the literature. Clin Psychol Rev. 2009;29:431–48.PubMedCrossRef
72.
Bass JK, Annan J, McIvor Murray S, et al. Controlled trial of psychotherapy for Congolese survivors of sexual violence. N Engl J Med. 2013;368:2182–91.PubMedCrossRef
Metadaten
Titel
Intimate Partner Violence and HIV: A Review
verfasst von
Reed A. C. Siemieniuk
Hartmut B. Krentz
M. John Gill
Publikationsdatum
01.12.2013
Verlag
Springer US
Erschienen in
Current HIV/AIDS Reports / Ausgabe 4/2013
Print ISSN: 1548-3568
Elektronische ISSN: 1548-3576
DOI
https://doi.org/10.1007/s11904-013-0173-9

Weitere Artikel der Ausgabe 4/2013

Current HIV/AIDS Reports 4/2013 Zur Ausgabe

Behavioral Aspects of HIV Management (RJ DiClemente and JL Brown, Section Editors)

Health Literacy: Impact on the Health of HIV-Infected Individuals

Behavioral Aspects of HIV Management (RJ DiClemente and JL Brown, Section Editors)

Intergenerational Sex as a Risk Factor for HIV Among Young Men Who Have Sex with Men: A Scoping Review

Behavioral Aspects of HIV Management (RJ DiClemente and JL Brown, Section Editors)

Validity of Cognitive Screens for HIV-Associated Neurocognitive Disorder: A Systematic Review and an Informed Screen Selection Guide

HIV/HCV Coinfection (N Terrault, Section Editor)

Treatment of Genotype 2 and Genotype 3 Hepatitis C Virus (HCV) Infection in Human Immunodeficiency Virus Positive Patients

Behavioral Aspects of HIV Management (RJ DiClemente and JL Brown, Section Editors)

Treatment Considerations for HIV-Infected Individuals with Severe Mental Illness

HIV/HCV Coinfection (N Terrault, Section Editor)

Treatment of Genotype 1 HCV Infection in the HIV Coinfected Patient in 2014

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

SGLT2-Inhibitoren und GLP-1-Rezeptoragonisten im Schlagabtausch

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Wer hat die Nase vorn – SGLT2-Inhibitoren oder GLP-1-Rezeptoragonisten? Diese Frage diskutierten zwei Experten in einer Session auf dem diesjährigen Diabetes-Kongress.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Delir bei kritisch Kranken – Antipsychotika versus Placebo

16.05.2024 Delir nicht substanzbedingt Nachrichten

Um die Langzeitfolgen eines Delirs bei kritisch Kranken zu mildern, wird vielerorts auf eine Akuttherapie mit Antipsychotika gesetzt. Eine US-amerikanische Forschungsgruppe äußert jetzt erhebliche Vorbehalte gegen dieses Vorgehen. Denn es gibt neue Daten zum Langzeiteffekt von Haloperidol bzw. Ziprasidon versus Placebo.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise